Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa.
D000284:Administration, Oral; D000368:Aged; D000618:Aminohippuric Acids; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced; D007444:Inulin; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D010300:Parkinson Disease / Q000188:drug therapy; D011187:Posture; D011188:Potassium / Q000652:urine*; D012964:Sodium / Q000652:urine*
D000618:Aminohippuric Acids; D004295:Dihydroxyphenylalanine; D007444:Inulin; D012964:Sodium; D011188:Potassium